Abstract
The current COVID-19 pandemic has represented a major challenge for society and the medical community, not only because of its high contagion but also because of the variability of clinical manifestations and its unpredictable behavior under different health contexts. Given this, specific preventive measures are relevant to avoid or reduce infections between patients and health unit personnel, considering that the presymptomatic period during which the infected individual can already transmit the virus varies between five and six or up to 14 days, according to data from the World Health Organization. In addition, an infected patient can be asymptomatic, even some people after having suffered COVID-19 can continue to shed virus for a few more days after recovering.References
Shaker MS, Oppenheimer J, Grayson M, Stukus D, Hartog N, Hsieh EWY, et al. COVID-19: pandemic contingency planning for the allergy and immunology clinic. J Allergy Clin Immunol Pract. 2020;8(5):1477-1488.e5. DOI: 10.1016/j.jaip.2020.03.012
American Academy of Allergy Asthma & Immunology [Internet]. AAAAI Immunotherapy, Allergen Standardization and Allergy Diagnostics Committee. Administration of subcutaneous allergen immunotherapy during the COVID-19 outbreak. EE. UU.: American Academy of Allergy Asthma & Immunology; 2020.
Getting your workplace ready for COVID-19 [En línea]. Suiza: Organización Mundial de la Salud; 2020. Disponible en: https://www.who.int/docs/default-source/coronaviruse/getting-workplace-ready-for-covid-19.pdf
Larenas-Linnemann D, Luna-Pech JA, Rodríguez-Pérez N, Rodríguez-González M, Arias-Cruz A, Blandón-Vijil MV, et al. GUIMIT 2019, Guía Mexicana de Inmunoterapia. Guía de diagnóstico de alergia mediada por IgE e inmunoterapia aplicando el método ADAPTE. Rev Alerg Mex. 2019;66(Supl 1):1-105. DOI: 10.29262/ram.v66i5.631
Secretaría de Salud [Internet]. Recomendaciones para personal de salud. México: Secretaría de Salud; 2020. Disponible en: https://www.gob.mx/salud/documentos/informacion-para-personal-de-salud

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2020 Revista Alergia México
